HEDY Group

HEDY Group is a Guangzhou, China-based diversified enterprise group whose current core businesses span big health, information technology, and real estate, with healthcare positioned as a major strategic growth area. Within healthcare, the group operates across biopharmaceuticals, cell therapy, hospital investment and management, dialysis services, medical device manufacturing, rehabilitation and eldercare-related equipment, and healthcare services. Public descriptions of the group highlight subsidiaries focused on antibody therapeutics, CAR-T/TCR-T cell therapy, anti-tumor chemical drugs and formulations, oncology hospital development, hemodialysis center operations, and medical imaging and life-support devices. HEDY Group appears to be a commercial-stage operating group rather than a single-product biotech, and its healthcare presence is best understood through its portfolio of subsidiaries and operating companies rather than a disclosed consolidated drug pipeline.